Senior insider sale
AKTIS ONCOLOGY, INC. — senior position signals high conviction
$77.3K
3.06K shares
What this filing means
HERRMANN KEN plans to sell 3.06K shares of AKTIS ONCOLOGY, INC. valued at approximately $77.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/17/2026ACC: 0001950047-26-007199
3.06K
Shares to sell
$77.3K
Approx. market value
3.06K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
7/17/2026
3.06KTotal acquired3.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/17/2026 | Stock Option Exercise Cash | 3.06K | — |
| Total | 3.06K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.06K
Market value
$77.3K
7/17/2026
Total
Units
3.06K
Value
$77.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/17/2026 | 3.06K | $77.3K | NASDAQ | Planned |
| Total | 3.06K | $77.3K | ||